Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact

Citations to this article

TCF-1 regulates HIV-specific CD8+ T cell expansion capacity
Rachel L. Rutishauser, … , Joseph M. McCune, Peter W. Hunt
Rachel L. Rutishauser, … , Joseph M. McCune, Peter W. Hunt
Published December 22, 2020
Citation Information: JCI Insight. 2021;6(3):e136648. https://doi.org/10.1172/jci.insight.136648.
View: Text | PDF
Research Article AIDS/HIV Immunology

TCF-1 regulates HIV-specific CD8+ T cell expansion capacity

  • Text
  • PDF
Abstract

Although many HIV cure strategies seek to expand HIV-specific CD8+ T cells to control the virus, all are likely to fail if cellular exhaustion is not prevented. A loss in stem-like memory properties (i.e., the ability to proliferate and generate secondary effector cells) is a key feature of exhaustion; little is known, however, about how these properties are regulated in human virus–specific CD8+ T cells. We found that virus-specific CD8+ T cells from humans and nonhuman primates naturally controlling HIV/SIV infection express more of the transcription factor TCF-1 than noncontrollers. HIV-specific CD8+ T cell TCF-1 expression correlated with memory marker expression and expansion capacity and declined with antigenic stimulation. CRISPR-Cas9 editing of TCF-1 in human primary T cells demonstrated a direct role in regulating expansion capacity. Collectively, these data suggest that TCF-1 contributes to the regulation of the stem-like memory property of secondary expansion capacity of HIV-specific CD8+ T cells, and they provide a rationale for exploring the enhancement of this pathway in T cell–based therapeutic strategies for HIV.

Authors

Rachel L. Rutishauser, Christian Deo T. Deguit, Joseph Hiatt, Franziska Blaeschke, Theodore L. Roth, Lynn Wang, Kyle A. Raymond, Carly E. Starke, Joseph C. Mudd, Wenxuan Chen, Carolyn Smullin, Rodrigo Matus-Nicodemos, Rebecca Hoh, Melissa Krone, Frederick M. Hecht, Christopher D. Pilcher, Jeffrey N. Martin, Richard A. Koup, Daniel C. Douek, Jason M. Brenchley, Rafick-Pierre Sékaly, Satish K. Pillai, Alexander Marson, Steven G. Deeks, Joseph M. McCune, Peter W. Hunt

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 Total
Citations: 8 9 10 13 9 1 50
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2025 (8)

Title and authors Publication Year
Persistent elite controllers as the key model to identify permanent HIV remission
Gasca-Capote C, Ruiz-Mateos E
Current Opinion in HIV and AIDS 2025
From natural defenders to therapeutic warriors: NK cells in HIV immunotherapy
Laeremans T, Janssens A, Aerts JL
Immunotherapy 2025
Combination immunotherapy induces post-intervention control of HIV
Peluso MJ, Sandel DA, Deitchman AN, Kim SJ, Dalhuisen T, Tummala HP, Tibúrcio R, Zemelko L, Borgo GM, Singh SS, Schwartz K, Deswal M, Williams MC, Hoh R, Shimoda M, Narpala S, Serebryannyy L, Khalili M, Vendrame E, SenGupta D, Whitmore LS, Tisoncik-Go J, Gale M Jr, Koup RA, Mullins JI, Felber BK, Pavlakis GN, Reeves JD, Petropoulos CJ, Glidden DV, Spitzer MH, Gama L, Caskey M, Nussenzweig MC, Chew KW, Henrich TJ, Yukl SA, Cohn LB, Deeks SG, Rutishauser RL
Research Square 2025
Impact of rosuvastatin on the memory potential and functionality of CD8+ T cells from people with HIV
Perdomo-Celis F, Passaes C, Monceaux V, Lambotte O, Costagliola D, Chevalier MF, Weiss L, Sáez-Cirión A
eBioMedicine 2025
Stem-like CD8+ T cells preserve HBV-specific responses in HBV/HIV co-infection
Preechanukul J, Alrubayyi A, Sun B, Arbe-Barnes E, Kokici J, Gorou F, Prasitdumrong S, da Costa KA, Fisher-Pearson N, Hussain N, Kucykowicz S, Ghosh I, Burns F, Kinloch S, Simoes P, Bhagani S, Kennedy PT, Maini MK, Bashford-Rogers R, Gill US, Peppa D
medRxiv 2025
Immune-mediated strategies to solving the HIV reservoir problem.
Kulpa DA, Paiardini M, Silvestri G
Nature reviews. Immunology 2025
AAV-HBV mouse model replicates the intrahepatic immune landscape of chronic HBV patients at single-cell level
Conceição-Neto N, Pierson W, Han Q, Yao Z, Wu Q, Dockx K, Aerts L, De Maeyer D, Beyens M, den Berge KV, Li C, Kukolj G, Zhu R, Krishna V, Podlaha O, Nájera I, Van Gulck E
Frontiers in Immunology 2025
Understanding the HIV-specific T-cell response to immune checkpoint blockade: what can we learn from cancer immunotherapy?
Gubser C, Kaufmann DE
Current Opinion in HIV and AIDS 2025

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts